Last update 29 Mar 2025

Eprosartan Mesylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(E)-2-butyl-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic acid, (E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid, (E)-α{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid
+ [18]
Target
Action
antagonists
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists)
Therapeutic Areas
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (22 Dec 1997),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H28N2O7S2
InChIKeyDJSLTDBPKHORNY-XMMWENQYSA-N
CAS Registry144143-96-4

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Essential Hypertension
Australia
15 Jun 1998
Hypertension
United States
22 Dec 1997
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
Essential Hypertension
N-terminal pro-brain natriuretic peptide (NT-proBNP)
165
esfcsgxthu(opdmmmbfyz) = orzifcfwpu jbuynegddz (viokrrbwgl )
-
27 Aug 2018
Phase 3
665
Placebo Eprosartan mesylate+Eprosartan
(Eprosartan)
gkmlqwqbrq(auzhqbkjpm) = xqhlbomdco glhuvthtbq (gljebhcrxm, 7.7)
-
26 May 2014
Placebo Eprosartan+Eprosartan Mesylate
(Eprosartan Mesylate)
gkmlqwqbrq(auzhqbkjpm) = yrhgvwgjim glhuvthtbq (gljebhcrxm, 7.5)
Phase 4
1,405
vuhcniudjm(hqciuubaiu) = aptnauhnbz vxoseuktsi (vcxfzinmly )
-
01 Jun 2005
vuhcniudjm(hqciuubaiu) = ybbgrrqlzh vxoseuktsi (vcxfzinmly )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free